Literature DB >> 19358898

A comparative analysis of binding sites between mouse CYP2C38 and CYP2C39 based on homology modeling, molecular dynamics simulation and docking studies.

Xuan-Yu Meng1, Qing-Chuan Zheng, Hong-Xing Zhang.   

Abstract

Mouse CYP2C38 and CYP2C39 are two closely related enzymes with 91.8% sequence identity. But they exhibit different substrate binding features. In this study, three-dimensional models of CYP2C38 and CYP2C39 were constructed using X-ray crystal structure of human CYP2C8 as the template based on homology modeling methods and molecular dynamics simulations. Tolbutamide as the common substrate of CYP2C38 and CYP2C39 was docked into them and positioned in their active sites with different orientation. All-trans retinoic acid (atRA) is a specific substrate for CYP2C39 and not catalyzed by CYP2C38. By comparison of active site architectures between CYP2C38 and CYP2C39, the possible reasons affecting their substrate binding were proposed. In addition, Arg241, Glu300, Leu366 and Leu476 are identified as critical residue for substrates binding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19358898     DOI: 10.1016/j.bbapap.2009.03.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  Molecular docking: a powerful approach for structure-based drug discovery.

Authors:  Xuan-Yu Meng; Hong-Xing Zhang; Mihaly Mezei; Meng Cui
Journal:  Curr Comput Aided Drug Des       Date:  2011-06       Impact factor: 1.606

2.  Analysis of clinically relevant substrates of CYP2B6 enzyme by computational methods.

Authors:  Rui-Juan Niu; Qing-Chuan Zheng; Ji-Long Zhang; Hong-Xing Zhang
Journal:  J Mol Model       Date:  2011-02-08       Impact factor: 1.810

Review 3.  Template-based protein modeling: recent methodological advances.

Authors:  Pankaj R Daga; Ronak Y Patel; Robert J Doerksen
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

4.  Small Heterodimer Partner Regulates Circadian Cytochromes p450 and Drug-Induced Hepatotoxicity.

Authors:  Tianpeng Zhang; Fangjun Yu; Lianxia Guo; Min Chen; Xue Yuan; Baojian Wu
Journal:  Theranostics       Date:  2018-10-22       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.